Analysis of the activated partial thromboplastin time test using mathematical modeling.

Activated partial thromboplastin time (APTT) is a laboratory test for the diagnosis of blood coagulation disorders. The test consists of two stages: The first one is the preincubation of a plasma sample with negatively charged materials (kaolin, ellagic acid etc.) to activate factors XII and XI; the second stage begins after the addition of calcium ions that triggers a chain of calcium-dependent enzymatic reactions resulting in fibrinogen clotting. Mathematical modeling was used for the analysis of the APTT test. The process of coagulation was described by a set of coupled differential equations that were solved by the numerical method. It was found that as little as 2.3 x 10(-9) microM of factor XIIa (1/10000 of its plasma concentration) is enough to cause the complete activation of factor XII and prekallikrein (PK) during the first 20 s of the preincubation phase. By the end of this phase, kallikrein (K) is completely inhibited, residual activity of factor XIIa is 54%, and factor XI is activated by 26%. Once a clot is formed, factor II is activated by 4%, factor X by 5%, factor IX by 90%, and factor XI by 39%. Calculated clotting time using protein concentrations found in the blood of healthy people was 40.5 s. The most pronounced prolongation of APTT is caused by a decrease in factor X concentration.

[1]  K. Mann,et al.  Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. , 1987, The Journal of biological chemistry.

[2]  S. Olson,et al.  High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein. , 1993, Biochemistry.

[3]  R. Colman,et al.  Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen. , 1982, The Journal of clinical investigation.

[4]  J. Dunn,et al.  Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. , 1980, The Journal of biological chemistry.

[5]  F Keller,et al.  The quick machine--a mathematical model for the extrinsic activation of coagulation. , 1994, Haemostasis.

[6]  G. Krishnan Radioimmunoassay for human prothrombin. , 1983, Clinical chemistry.

[7]  M A Khanin,et al.  A mathematical model of the kinetics of blood coagulation. , 1989, Journal of theoretical biology.

[8]  S. Levine,et al.  Enzyme Amplifier Kinetics , 1966, Science.

[9]  R. Rosenberg,et al.  The isolation and characterization of a specific antibody population directed against the thrombin antithrombin complex. , 1980, The Journal of biological chemistry.

[10]  P. Lollar,et al.  von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain. , 1990, The Journal of biological chemistry.

[11]  D. Sinha,et al.  Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX. , 1987, Biochemistry.

[12]  M. Poon,et al.  Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease. , 1978, The Journal of laboratory and clinical medicine.

[13]  J. Finlayson,et al.  Kinetics of activation and autoactivation of human factor XII. , 1984, Biochemistry.

[14]  K. Mann,et al.  Prothrombinase complex assembly. Kinetic mechanism of enzyme assembly on phospholipid vesicles. , 1988, The Journal of biological chemistry.

[15]  M. Scully,et al.  Inhibition of prothrombinase complex by plasma proteinase inhibitors. , 1984, Biochemistry.

[16]  R. Colman,et al.  The regulation of human factor XIIa by plasma proteinase inhibitors. , 1985, The Journal of biological chemistry.

[17]  G. Broze,et al.  Factor XI activation in a revised model of blood coagulation , 1991, Science.

[18]  R. Colman Hemostasis and thrombosis: Basic principles and clinical practice , 1987 .

[19]  H C Hemker,et al.  Analysis of thrombin generation in plasma. , 1994, Computers in biology and medicine.

[20]  M. Hultin Role of human factor VIII in factor X activation. , 1982, The Journal of clinical investigation.

[21]  R. Colman,et al.  Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies. , 1992, The Journal of biological chemistry.

[22]  D. Sinha,et al.  Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX. , 1984, The Journal of clinical investigation.

[23]  H C Hemker,et al.  The role of phospholipids and factor Va in the prothrombinase complex. , 1980, The Journal of biological chemistry.

[24]  J. Oliver,et al.  Thrombin activates factor XI on activated platelets in the absence of factor XII. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[25]  J. Dunn,et al.  The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein. , 1982, The Journal of biological chemistry.

[26]  J. Griffin,et al.  Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII. , 1977, The Journal of biological chemistry.

[27]  S. Iwanaga,et al.  Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions. , 1985, European journal of biochemistry.

[28]  A. Schmaier,et al.  Initiation of Blood Coagulation at Artificial Surfaces , 1987, Annals of the New York Academy of Sciences.

[29]  S. Rapaport,et al.  Radioimmunoassays for protein C and factor X. Plasma antigen levels in abnormal hemostatic states. , 1984, American journal of clinical pathology.

[30]  H. Hemker,et al.  The effect of platelets in the activation of human blood coagulation factor IX by factor XIa , 1986 .

[31]  M. Verstraete,et al.  Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration , 1977, European journal of clinical investigation.

[32]  J. Griffin Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Mann,et al.  "Clotspeed," a mathematical simulation of the functional properties of prothrombinase. , 1984, The Journal of biological chemistry.

[34]  M A Khanin,et al.  Mathematical model for the blood coagulation prothrombin time test. , 1998, Thrombosis research.

[35]  J. Margolis THE INTERRELATIONSHIP OF COAGULATION OF PLASMA AND RELEASE OF PEPTIDES , 1963, Annals of the New York Academy of Sciences.

[36]  C. L. La Porta,et al.  Activation of factor XI in plasma is dependent on factor XII. , 1993, Blood.

[37]  K. Mann,et al.  Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. , 1985, The Journal of biological chemistry.

[38]  S. Bajaj,et al.  Intrinsic versus extrinsic coagulation. Kinetic considerations. , 1986, The Biochemical journal.

[39]  Kenneth G. Mann,et al.  An Integrated Study of Fibrinogen during Blood Coagulation* , 1999, The Journal of Biological Chemistry.

[40]  R J Leipold,et al.  Mathematical Model of Serine Protease Inhibition in the Tissue Factor Pathway to Thrombin (*) , 1995, The Journal of Biological Chemistry.

[41]  G M Oosta,et al.  The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. , 1980, The Journal of biological chemistry.

[42]  H. Suomela Human coagulation factor IX. Isolation and characterization. , 1976, European journal of biochemistry.

[43]  E. Kruithof,et al.  Plasminogen Activator Inhibitor 1 and Plasminogen Activator Inhibitor 2 in Various Disease States , 1988, Thrombosis and Haemostasis.

[44]  K. Fujikawa,et al.  Mechanism of activation of bovine factor XI by factor XII and factor XIIa. , 1980, Biochemistry.

[45]  D. A. Molchanova,et al.  [A simulated mathematical model of the blood coagulation system intrinsic pathway]. , 1995, Biofizika.

[46]  K. Mann,et al.  A model for the tissue factor pathway to thrombin. II. A mathematical simulation. , 1994, The Journal of biological chemistry.

[47]  D D Monkovic,et al.  Activation of human factor V by factor Xa and thrombin. , 1990, Biochemistry.

[48]  W J Brittain,et al.  Contact activation of the plasma coagulation cascade. I. Procoagulant surface chemistry and energy. , 1995, Journal of biomedical materials research.

[49]  J Jesty,et al.  Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin. , 1994, Biochemistry.

[50]  J. Shafer,et al.  Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin. , 1983, The Journal of biological chemistry.

[51]  K. Mann,et al.  Radioimmunoassay of factor V in human plasma and platelets. , 1982, Blood.

[52]  C. Mannhalter,et al.  Phospholipids accelerate factor IX activation by surface bound factor XIa , 1984, British journal of haematology.

[53]  B. Lämmle,et al.  A quantitative dot immunobinding assay for coagulation factor XII in plasma. , 1990, Journal of immunological methods.

[54]  R. Colman,et al.  Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor. , 1984, The Journal of clinical investigation.

[55]  A. Schmaier,et al.  Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor. , 1987, Archives of biochemistry and biophysics.

[56]  K. Mann,et al.  Biochemistry and Physiology of Blood Coagulation , 1999, Thrombosis and Haemostasis.

[57]  H C Hemker,et al.  Simulation model for thrombin generation in plasma. , 1991, Haemostasis.

[58]  J. Griffin,et al.  Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system. , 1989, The Journal of biological chemistry.

[59]  K. Mann,et al.  Comparison of the inhibition of thrombin by three plasma protease inhibitors. , 1978, Biochemistry.

[60]  K Fujikawa,et al.  Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. , 1991, The Journal of biological chemistry.

[61]  M. Shuman,et al.  Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. , 1985, The Journal of clinical investigation.

[62]  J. Miletich,et al.  Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. , 1989, The Journal of biological chemistry.

[63]  R. Colman,et al.  Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[64]  R. Bertina,et al.  The Role of Factor VIII in the Activation of Human Blood Coagulation Factor X by Activated Factor IX , 1985, Thrombosis and Haemostasis.

[65]  K. Mann,et al.  A model for the tissue factor pathway to thrombin. I. An empirical study. , 1994, The Journal of biological chemistry.

[66]  P. Walsh,et al.  Kinetics of coagulation factor X activation by platelet-bound factor IXa. , 1990, Biochemistry.

[67]  J. Travis,et al.  Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. , 1980, The Journal of biological chemistry.

[68]  Semenov Vv,et al.  Nonlinear effects in kinetics of blood coagulation , 1990 .

[69]  O. Ratnoff,et al.  A new method for the determination of fibrinogen in small samples of plasma. , 1951, The Journal of laboratory and clinical medicine.

[70]  S. Bajaj Cooperative Ca2+ binding to human factor IX. Effects of Ca2+ on the kinetic parameters of the activation of factor IX by factor XIa. , 1982, The Journal of biological chemistry.